Log in

Company updateCNBC-TV18

Natco Pharma receives EIR from US FDA for Visakhapatnam plant

Positive+20

GreyOak summary

GreyOak has no summary for this story yet.

What it affects

Source

Reported by CNBC-TV18

More Natco Pharma news

All Natco Pharma news →

The company today

Price, day change, sector and market cap of the companies this story names
CompanyPriceDay changeSectorMarket cap
Natco PharmaNATCOPHARM · NSE₹817.50−0.54%Healthcare₹16,037 crore

Prices as of ; the last session's close when the market is shut. Research, not investment advice.

Latest market news

News Intelligence →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy